BeOne Medicines (ONC) Current Assets (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Current Assets data on file, last reported at $6.6 billion in Q1 2026.

• On a quarterly basis, Current Assets rose 69.42% year-over-year to $6.6 billion in Q1 2026; TTM through Mar 2026 was $6.6 billion, a 69.42% increase from a year earlier, with the FY2025 full-year figure at $6.2 billion, up 56.17% from the prior year.
• Current Assets for Q1 2026 stood at $6.6 billion, up from $6.2 billion in the prior quarter.
• Over the last five years, Current Assets for ONC reached as high as $6.9 billion in Q1 2022 and fell as low as $3.1 billion in Q4 2022.
• Historically, Current Assets has averaged $4.8 billion across 5 years, with a median of $4.3 billion in 2025.
• Across the five-year window, Current Assets sank 59.33% in 2022 and surged 69.42% in 2026, its largest moves.
• Year by year, Current Assets stood at $3.1 billion in 2022, then soared by 35.74% to $4.2 billion in 2023, then fell by 5.04% to $4.0 billion in 2024, then jumped by 56.17% to $6.2 billion in 2025, then rose by 5.9% to $6.6 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $6.6 billion in Q1 2026, $6.2 billion in Q4 2025, and $5.7 billion in Q3 2025.